Syn One Test News Today

Researchers hope the tests will enable faster, more accurate diagnosis and aid in future treatment development.

A skin biopsy that can detect an abnormal protein in cutaneous nerve fibers holds promise for early detection of Parkinson's and other neurodegenerative disorders.

A recent study published in the Journal of the American Medical Association (JAMA) has revealed that a simple skin biopsy test could help detect Parkinson's disease with an impressive 93% accuracy rate.

Traditionally, doctors diagnosed Parkinson’s first by symptoms: freezing when walking, stiffness and tremors.

Doctors have a new tool to diagnose Parkinson's disease, which (behind Alzheimer's) is the second-most common neurodegenerative disorder in the US. Per the Wall Street...

A commercially available skin test to aid Parkinsons disease diagnosis is available in most states. How do clinicians use it? Could it help in the development of alpha-synuclein-targeted therapies?

Hosted by AZBio CEO Joan Koerber-Walker, the 2023 AZBio Awards honored the most innovative bioscience leaders and companies in Arizona.

/PRNewswire/ -- CND Life Sciences, a medical technology company pioneering the development of skin-based tests to help clinicians diagnose neurodegenerative...

/PRNewswire/ -- CND Life Sciences, a medical technology company pioneering the development of cutaneous neurodiagnostics, today announced topline results from...

CND raised an additional $1 million in venture financing from Top Corner CapitalSCOTTSDALE, Ariz., April 6, 2023 /PRNewswire/ -- CND Life Sciences...